文献速递血栓与止血

创伤与脓毒症相关凝血病的机制与管理:创伤诱导性凝血病、脓毒症诱导性凝血病与弥散性血管内凝血

Mechanisms and management of the coagulopathy of trauma and sepsis: trauma-induced coagulopathy, sepsis-induced coagulopathy, and disseminated intravascular coagulation.
PubMed 文献 · J Thromb Haemost · 2023-09-16

综述阐述创伤诱导性凝血病(TIC)与脓毒症诱导性凝血病(SIC)及弥散性血管内凝血的机制与管理。约25%严重创伤患者到院时即存在TIC,初期为低凝出血表型、后期可转为促血栓与低纤溶状态;SIC早期常伴多器官功能障碍而缺乏出血期。管理包括处理病因、止血复苏与循环支持,指南推荐辅助治疗。

要点

  • 约25%严重创伤患者到院时即出现创伤诱导性凝血病,初期表现为止血受损与出血表型。
  • TIC后期可进展为促血栓与低纤溶状态(纤溶关闭),炎症介质释放、内皮损伤和血小板失调参与促进。
  • SIC与TIC表型不同,SIC早期常伴多器官功能障碍而缺乏出血期;两者均有内皮损伤、纤溶失调和凝血异常。

核心结论

  • TIC与SIC表型不同,但内皮损伤、纤溶失调和凝血异常为两者共同特征。
  • 管理包括治疗病因(区分组织损伤与感染)、止血复苏和循环支持等支持治疗,指南推荐辅助治疗。
  • 基于临床研究和部分指南,辅助治疗包括在创伤初期有限时间窗内使用氨甲环酸,以及弥散性血管内凝血中使用抗凝血酶、重组血栓调节蛋白等抗凝药。

研究设计与样本

  • 综述,检索范围原文未报告。

主要发现

  • 约25%严重创伤患者到院时发生TIC,初期止血受损并呈出血表型,后期可进展为促血栓期。
  • 创伤后止血失效由大量失血、组织损伤和纤溶亢进驱动,持续至手术或其他管理措施控制出血原因,并进展为促血栓与低纤溶状态(纤溶关闭)。
  • 炎症介质释放、内皮损伤和血小板失调促进促血栓进展,常见于脓毒症并伴死亡率增加。
  • 与TIC不同,脓毒症早期常并发多器官功能障碍,即SIC,缺乏出血期。
  • TIC存活者后续可能发生感染并潜在发展为脓毒症和SIC。

关键数值与推荐

  • 约25%严重创伤患者到院时发生TIC。
  • 指南推荐辅助治疗。
  • 氨甲环酸用于创伤初期有限时间窗。
  • 抗凝血酶和重组血栓调节蛋白用于弥散性血管内凝血。

临床怎么用

  • 治疗病因是关键,需区分组织损伤与感染。
  • 止血复苏和循环支持等支持治疗必不可少。
  • 指南推荐辅助治疗;基于临床研究和部分指南,创伤初期有限时间窗内可使用氨甲环酸。
  • 基于临床研究和部分指南,弥散性血管内凝血可使用抗凝血酶和重组血栓调节蛋白等抗凝药。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Disseminated intravascular coagulation can occur due to different causes but commonly following sepsis. Trauma-induced coagulopathy (TIC) occurs on hospital arrival in approximately 25% of seriously injured patients who initially presents with impaired hemostasis and a bleeding phenotype that can later progress to a prothrombotic phase. Following traumatic injury, ineffective hemostasis is driven by massive blood loss, tissue damage, and hyperfibrinolysis. This initial impaired hemostasis continues until surgical or other management strategies not only to stop the causes of hemorrhage but also progresses to a prothrombotic and hypofibrinolytic state, also termed fibrinolytic shutdown. Prothrombotic progression is also promoted by inflammatory mediator release, endothelial injury, and platelet dysregulation, which is commonly seen in sepsis with increased mortality. Unlike TIC, the early phase of sepsis is frequently complicated by multiorgan dysfunction described as sepsis-induced coagulopathy (SIC) that lacks a hemorrhagic phase. The phenotypes of SIC and TIC are different, especially in their initial presentations; however, patients who survive TIC may also develop subsequent infections and potentially sepsis and SIC. Although the pathophysiology of SIC and TIC are different, endothelial injury, dysregulated fibrinolysis, and coagulation abnormalities are common. Management includes treatment of the underlying cause, tissue injury vs infection is critical, and supportive therapies, such as hemostatic resuscitation and circulatory support are essential, and adjunct therapies are recommended in guidelines. Based on clinical studies and certain guidelines, additional therapies include tranexamic acid in the limited timing of initial traumatic injury and anticoagulants, such as antithrombin and recombinant thrombomodulin in disseminated intravascular coagulation.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Iba T, Helms J, Neal MD, et al. Mechanisms and management of the coagulopathy of trauma and sepsis: trauma-induced coagulopathy, sepsis-induced coagulopathy, and disseminated intravascular coagulation. J Thromb Haemost. 2023. PMID: 37722532. doi:10.1016/j.jtha.2023.05.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。